FMFraser Massie

Fraser Massie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fraser Massie has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An automated metabolite extraction workflow for global metabolomics analysis using the Agilent Bravo liquid handling platform

    by Fraser Massie, Andrew MacKenzie, Sufyan Pandor, Mauro A. Cremonini, Tessa Moses

    Metabolomics is the comprehensive study of small molecules that provides a snapshot of an organism’s physiological state. Reflecting phenotype more closely than genes or proteins, metabolites reveal changes linked to diseases, mutations, genetic interventions, and environmental stimuli. Recent technological advancements in metabolomics analysis through the application of ion mobility mass spectrometry have enhanced the comprehensive analysis of complex metabolic mixtures. However, pre-analytical bottlenecks in throughput and consistent extraction persist. We developed an automated, sample-agnostic metabolite extraction workflow for diverse liquid samples using an Agilent Bravo liquid handling platform. Here, we provide device, protocol, and form files for efficient sample processing to extract metabolites for global metabolomics analysis using liquid chromatography – mass spectrometry techniques.


  • Open Access

    Dissecting cell death pathways in fed‐batch bioreactors

    by David A. Mentlak, John Raven, Tessa Moses, Fraser Massie, Nicholas Barber, Robyn Hoare, Graeme Burton, Alison Young, Leon P. Pybus, Susan Rosser, et al.

    Chinese hamster ovary (CHO) cells are widely used for production of biologics including therapeutic monoclonal antibodies. Cell death in CHO cells is a significant factor in biopharmaceutical production, impacting both product yield and quality. Apoptosis has previously been described as the major form of cell death occurring in CHO cells in bioreactors. However, these studies were undertaken when less was known about non‐apoptotic cell death pathways. Here, we report the occurrence of non‐apoptotic cell death in an industrial antibody‐producing CHO cell line during fed‐batch culture. Under standard conditions, crucial markers of apoptosis were not observed despite a decrease in viability towards the end of the culture; only by increasing stress within the system did we observe caspase activation indicative of apoptosis. In contrast, markers of parthanatos and ferroptosis were observed during standard fed‐batch culture, indicating that these non‐apoptotic cell death pathways contribute to viability loss under these conditions. These findings pave the way for targeting non‐conventional cell death pathways to improve viability and biologic production in CHO cells.